Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.120
+0.010 (0.47%)
At close: Mar 10, 2026
41.33%
Market Cap 1.19B
Revenue (ttm) 1.02B
Net Income (ttm) 200.50M
Shares Out 560.25M
EPS (ttm) 0.36
PE Ratio 5.92
Forward PE n/a
Dividend 0.27 (12.93%)
Ex-Dividend Date Jun 24, 2025
Volume 64,000
Average Volume 88,400
Open 2.120
Previous Close 2.110
Day's Range 2.070 - 2.120
52-Week Range 1.405 - 2.550
Beta 0.33
RSI 55.63
Earnings Date Mar 30, 2026

About HKG:8049

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It markets its products under the Changlong and Qing Tong brands. The company also engages in the manufacture and distribution... [Read more]

Sector Healthcare
Founded 1989
Employees 798
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8049
Full Company Profile

Financial Performance

In 2024, HKG:8049's revenue was 881.16 million, an increase of 4.71% compared to the previous year's 841.55 million. Earnings were 184.25 million, an increase of 24.32%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.